Precision Radiomodulation Research
Treatment-Resistant Depression
Feasibility StudyActive
Key Facts
About ZAP Surgical
ZAP Surgical is a private medical device company that has developed the ZAP-X, a next-generation, dedicated cranial stereotactic radiosurgery platform. Its key innovations include self-shielding that eliminates the need for costly radiation bunkers, cobalt-free linear accelerator technology, and a unique gyroscopic delivery system designed for superior dosimetry. The company is in the commercial stage, with systems installed in clinical centers globally, and is exploring new clinical applications like radiomodulation for psychiatric conditions.
View full company profileTherapeutic Areas
Other Treatment-Resistant Depression Drugs
| Drug | Company | Phase |
|---|---|---|
| DB104 (Liafensine) | Denovo Biopharma | Phase 2b |
| VNS Therapy for TRD | LivaNova | PMA Supplement |
| NOE-101 (basimglurant) | Noema Pharma | Phase 2b |
| PCN-101 (R-ketamine) | Perception Neuroscience | Phase 2a |
| mGlu2 NAM Program for TRD | Camino Pharma | Pre-clinical |
| TAK-653 | Thermo Fisher Scientific | Phase 2 |
| SPN-820/821 | Supernus Pharmaceuticals | Phase 3 |
| BPL-003 | atai Life Sciences | Phase 2 |
| VLS-01 | atai Life Sciences | Phase 2 |